DEEP Informatics: Deep Informatics++ Closes $14 Million Series B for AI-based Pathology Products

Deep Informatics++ of Hangzhou, a company that offers AI-based pathology products, completed a Series B financing of over $14 million. Founded in January 2017, Deep Informatics++ uses proprietary AI algorithms to develop multi-module diagnostic tools. Its products include: D-CleverEye (adds AI analysis to a microscope), D-PathAI (AI-assisted pathology diagnosis), and DPathAIS (an AI-based workstation). The round was led by CICC Fengtai Fund, a China Capital Investment Group fund, with participation from Legend Capital and Jiangmen Venture Capital. More details....Share this with colleagues: